Nicolas Kostelecky
Overview
Explore the profile of Nicolas Kostelecky including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
18
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kostelecky N, Loxas M, Multz R, Flanagan M, Ahrendsen J, Goldstein J
Am J Forensic Med Pathol
. 2024 Jul;
45(4):e107-e109.
PMID: 39018441
No abstract available.
2.
Kostelecky N, Wadhwani N, Golubovich I, Vormittag-Nocito E, Gao J, Jennings L, et al.
J Neuropathol Exp Neurol
. 2024 Jul;
83(12):1081-1083.
PMID: 38964372
No abstract available.
3.
Kahaki S, Hagemann I, Cha K, Trindade C, Petrick N, Kostelecky N, et al.
J Med Imaging (Bellingham)
. 2024 Feb;
11(1):017502.
PMID: 38370423
Purpose: Endometrial cancer (EC) is the most common gynecologic malignancy in the United States, and atypical endometrial hyperplasia (AEH) is considered a high-risk precursor to EC. Hormone therapies and hysterectomy...
4.
Stamm B, DiBiase R, Lee J, Primdahl D, Malavia T, Dixit K, et al.
Stroke
. 2023 Aug;
54(10):e448-e451.
PMID: 37534510
No abstract available.
5.
Wu S, Jia D, Schwartz M, Mulcahy M, Guo K, Tate M, et al.
CNS Oncol
. 2023 May;
12(3):CNS99.
PMID: 37219390
We recently reported the largest trial of breast cancer patients with HER2 positive leptomeningeal metastases (LM) treated with trastuzumab. An additional treatment indication was explored as part of a single...
6.
Kahaki S, Hagemann I, Cha K, Trindade C, Petrick N, Kostelecky N, et al.
Proc SPIE Int Soc Opt Eng
. 2023 May;
12471.
PMID: 37159719
Endometrial cancer (EC) is the most common gynecologic malignancy in the US and complex atypical hyperplasia (CAH) is considered a high-risk precursor to EC. Treatment options for CAH and early-stage...
7.
Jimenez J, Kostelecky N, Mitchell J, Zhang K, Lin C, Lenihan D, et al.
Cardiooncology
. 2023 Mar;
9(1):14.
PMID: 36915213
Background: Immune checkpoint inhibitor (ICI) myocarditis is associated with high morbidity and mortality. While endomyocardial biopsy (EMB) is considered a gold standard for diagnosis, the sensitivity of EMB is not...
8.
Kostelecky N, Kreutz K, Lin C
Am J Forensic Med Pathol
. 2022 Dec;
44(1):21-24.
PMID: 36580385
Pericarditis is a challenging diagnosis with nonspecific manifestations, significant clinical implications, and possible mortality. The advancement of imaging, such as echocardiography, computed tomography (CT), and magnetic resonance imaging (MRI), has...
9.
Bermea K, Kostelecky N, Rousseau S, Lin C, Adamo L
Front Immunol
. 2022 Oct;
13:973211.
PMID: 36248879
Introduction: Cardiac immunology studies in murine models have identified a sizeable population of myocardial B-cells and have shown that its modulation represents a promising strategy to develop novel therapies for...
10.
Kostelecky N, Ozhegov E, Cao D, Krigman H
Int J Gynecol Pathol
. 2022 Aug;
42(4):398-402.
PMID: 36044318
Cholangiocarcinoma is an uncommon and aggressive malignancy of intrahepatic and extrahepatic bile ducts. We present a case of a 37-year-old woman with cholangiocarcinoma metastatic to the endometrium that mimicked a...